Inventor
STANSFIELD IAN
IT16 patents
⚠️ This page may combine multiple inventors who share the name “STANSFIELD IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANGELETTI P IST RICHERCHE BIO
7 patentsUS7091209B2Aug 15, 2006
Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors
ANGELETTI P IST RICHERCHE BIO22 citations92
US7662809B2Feb 16, 2010
Tetracyclic indole derivatives as antiviral agents
ANGELETTI P IST RICHERCHE BIO11 citations82
US7119073B2Oct 10, 2006
Peptides and their use as inhibitors of hepatitis C virus ns3 protease
ANGELETTI P IST RICHERCHE BIO14 citations81
US7781422B2Aug 24, 2010
Antiviral indoles
ANGELETTI P IST RICHERCHE BIO4 citations62
US7767660B2Aug 3, 2010
Antiviral indoles
ANGELETTI P IST RICHERCHE BIO3 citations62
US7795247B2Sep 14, 2010
Tetracyclic indole derivatives as antiviral agents
ANGELETTI P IST RICHERCHE BIO2 citations59
US7989438B2Aug 2, 2011
Therapeutic compounds
ANGELETTI P IST RICHERCHE BIO1 citations48
JANSSEN PHARMACEUTICA NV
6 patentsUS11236084B2Feb 1, 2022
Substituted azaindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11186589B2Nov 30, 2021
Cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11180487B2Nov 23, 2021
Substituted cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11136311B2Oct 5, 2021
Heteroaromatic derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11001569B2May 11, 2021
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US9688662B2Jun 27, 2017
N-(2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5-yl)-4-quinazolinamine and N-(2,3-dihydro-1H-indol-5-yl)-4-quinazolinamine derivatives as perk inhibitors
JANSSEN PHARMACEUTICA NV0 citations32